Ledger.Open graph →
SEC Form D · filed December 14, 2023

SYNNOVATION THERAPEUTICS, INC

Offering
$102.5M
Sold
$69.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Wenqing Yao · Wilmington, DEExec · DirectorTing Feng · Wilmington, DEDirectorLiangxing Wu · Wilmington, DEExec · DirectorReid Huber · Wilmington, DEDirectorWenqing Yao · Wilmington, DEExec · DirectorTing Feng · Wilmington, DEDirectorReid Huber · Wilmington, DEDirectorLiangxing Wu · Wilmington, DEExec · DirectorIsaac Kato · Bellevue, WAExec · DirectorAnthony F. Mirra · New York, NYExec · DirectorDrew Walker · Boston, MADirectorMathilde Sanson · Camas, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗